In particular, several comprehensive analyses of the genomic profile of ACC have been performed, showing a complex genomic landscape with the identification of recurring mutations in different genes such as ZNFR (20%), CTNNB1 (14%), TP53 (14%), and RB1 (11%) [3, 17, 18]. This evidence concerns the gene CTNNB1 and adrenal cortex carcinoma.